A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station. Thanks to international ...

A UCO team has applied the genome editing technique, which garnered a Nobel Prize in Chemistry in 2020, to unravel the ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Continue advancing our next-generation gene editing and lipid nanoparticle (LNP) delivery platform for ... CASGEVY is a non-viral, ex vivo CRISPR/Cas9 gene-edited cell therapy for eligible ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

CRISPR Therapeutics continues to make significant progress in advancing its proprietary LNP delivery technologies for gene editing ... CASGEVY is a non-viral, ex vivo CRISPR/Cas9 gene-edited cell ...